Business
First Participant Dosed in PARs Phase 2b OA Clinical Trial
First Participant Dosed in PARs Phase 2b OA Clinical Trial
About this update from Paradigm Biopharmaceuticals Ltd.
[{"type":"text","content":"Paradigm Biopharmaceuticals Ltd has released a press release. View Attachment","length":265,"tagName":"div"}]